期刊
NEUROSCIENCE LETTERS
卷 468, 期 3, 页码 320-325出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2009.11.024
关键词
Alzheimer's disease; Lymphocytes; G(1)/S checkpoint; P53; Conformation
资金
- National Natural Science Key Foundation of China [30830045]
- National Key Technology RD Program [2006BAI02B01]
- National Basic Research 973 Program [2006CB500700]
- Beijing Natural Science Key Foundation [7071004]
- Ministry of Education of the People's Republic of China
To date, Alzheimer disease (AD) is still difficult to be diagnosed in its earliest stage. The cell cycle aberrations may be the earliest neuropathological events detected in AD thus far. The cell cycle regulatory failure in AD occurring at G(1)/S transition checkpoint which is mediated by the tumor suppressor protein p53 has been identified. Herein, we observed the response of activated lymphocytes to G(1)/S transition blocker to assess the G(1)/S checkpoint function and the p53 conformation state adopted in lymphocytes from AD patients and healthy non-AD controls. We found that the activated lymphocytes from AD patients were less sensitive to G(1)/S transition blocker than those from controls, indicating that the G(1)/S checkpoint failed to function well in AD lymphocytes. In addition, AD cells specifically expressed an anomalous conformationally mutant-like p53 that made these cells distinct from lymphocytes of controls. We speculated that the altered conformational p53 probably be responsible for G(1)/S checkpoint dysfunction in AD cells. Our hypothesis was supported by the results that G(1)/S checkpoint dysfunction was not restricted to neurons in AD patients, but also occurred in peripheral lymphocytes. Two potential biomarkers were indicated in blood lymphocytes from AD patients: the G(1)/S checkpoint dysfunction and the conformationally mutant-like p53 protein. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据